Join Relievus

If you're a physician, and you're looking for a better way to deliver care, consider joining our team.

Find out more

Call to schedule your appointment today

888-985-2727 (ASAP)

relievusAdmin

About relievusAdmin

This author has not yet filled in any details.
So far relievusAdmin has created 167 entries.

Ready, Set, Grow

With a company gaining a permit to open a medical marijuana growing and dispensing facility in Vineland, and area doctors prescribing it, questions loom.

http://www.snjtoday.com/category/327586/test-newspaper

By |January 16th, 2019|Categories: Uncategorized||Comments Off

How CBD works?

All cannabinoids, including CBD, attach themselves to certain receptors in the body to produce their effects.The human body produces certain cannabinoids on its own. It has two receptors for cannabinoids, called CB1 receptors and CB2 receptors. CB1 receptors are found all around the body, but many of them are in the brain.The CB1 receptors in the brain deal with coordination and movement, pain, emotions and mood, thinking, appetite, and memories, among others. THC attaches to these receptors.CB2 receptors are more common in the immune system. They have an effect on inflammation and pain.It used to be thought that CBD acts on these CB2 receptors, but it appears now that CBD does not act on either receptor directly. Instead, it seems to influence the body to use more of its own cannabinoids.

Click here to purchase the CBD products!

By |December 15th, 2018|Categories: News||Comments Off

What is CBD?

CBD is one of over 60 compounds found in cannabis that belong to a class of ingredients called cannabinoids. Until recently, THC (tetrahydrocannabinol) was getting most of the attention because it’s the ingredient in cannabis that produces mind-altering effects in users, but CBD is also present in high concentrations and the medical world is realizing that its list of medical benefits continues to grow. CBD is the major nonpsychoactive component of Cannabis sativa. According to a 2013 study published in the British Journal of Clinical Pharmacology, CBD benefits including acting in some experimental models as an anti-inflammatory, anticonvulsant, antioxidant, antiemetic, anxiolytic and antipsychotic agent, and is therefore potential medicine for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, anxiety and schizophrenia. Research is beginning to show that CBD is different than other well-studied cannabinoids. All cannabinoids act as ligands, meaning they dock onto the binding site of a protein and have the ability to modulate a receptor’s behavior. CB1 receptors are widely distributed, but are particularly abundant in areas of the brain, including those concerned with movement, coordination, pain and sensory perception, emotion, memory, cognition, autonomic and endocrine functions. CB2 receptors are found mostly in the immune system, and they seem to reduce inflammation and certain kinds of pain. Although cannabinoids all have similar structures, they display a wide array of actions at each of the different receptors.However, scientists are finding out that CBD has very little effect on CB1 and CB2 receptors, which probably explains why it doesn’t have mind-altering effects, unlike THC, which positively regulates the CB1 receptor. That’s why most marijuana grown for recreational purposes are typically very low in CBD and high in THC.

Click here to find out more information!

By |November 15th, 2018|Categories: News||Comments Off

What is ENR?

ENR stands for Electro Nerve Regeneration, and it is a type of therapy that uses electricity to relive nerve pain. it is intended to alleviate pain, tingling, burning and numbness resulting from neuropathy and chronic nerve conditions. It has proven especially effective for treating diabetic neuropathy and nerve pain, but can treat a wide range of conditions, including:

Carpal Tunnel Syndrome

Complex Regional Pain Syndrome

Diabetic Neuropathy

Neuritis

Peripheral Neuropathy

Radiculopathy

ENR patients have regained improved sensation, range of motion, balance and restful sleep as well as eliminated pain and numbness. The treatment in nonsurgical and noninvasive.

By |October 15th, 2018|Categories: News||Comments Off

Telehealth Can Connect the Dots Between Chronic Pain, Mental Health

 - Telehealth advocates have argued that a connected health platform can help providers improve care management for patients with chronic pain. A New Jersey-based pain management and neurology clinic is putting that idea to the test.

Relievus Pain Management, based in Cherry Hill, N.J., and serving a wide swath of New Jersey and Pennsylvania, has added a telemedicine platform to its list of treatments, which include medical marijuana, stem cell therapy, Ketamine infusion and electromedical therapy. The virtual care service enables the 20-site clinic’s 28 providers to monitor patients at home every day and change care plans as needed.

More importantly, the telehealth platform, developed by a Philadelphia-based startup called NeuroFlow, gives providers insight into the patient’s mental health – a key indicator of care plan adherence and an underlying cause for opioid addiction issues.

“We used to focus on one thing – the patient’s physical health,” says Young J. Lee, MD, a pain specialist and anesthesiologist and the clinic’s managing partner. “We used to document (a patient’s mental status), but we didn’t do anything about it. Now we’re paying attention to mental health and we’re realizing that pain is not just a physical issue. This is a physical and mental issue.”

Relievus integrated the NeuroFlow platform roughly three months ago. Participating patients are now able to download an app on their smartphone or mobile device, on which they log in each day to fill out an online questionnaire about their physical and mental health. On the other end, their care provider logs onto a dashboard each day to review the patient’s status and make changes to the care plan if needed.

Lee says the online platform is a vast improvement over the old method, in which providers asked patients to fill out a paper or tablet-based survey during their monthly visit. Patients were asked to think back over the previous month and try to describe their experiences – from which the provider would then have to decide whether to alter the care plan or keep going.

“Now we’re able to see on a daily basis how each patient is doing,” Lee says.

When factoring mental health into the treatment plan, that’s important. By listening to how each patient goes through his or her day, and how pain affects that daily routine, providers can begin to understand how pain affects the patient’s mental health. This, in turn, can lead to a better understanding of issues like stress, depression and addiction.

Lee says the mHealth platform is customizable, so that he can work with NeuroFlow’s technical team to select questions that address a specific condition. He anticipates modeling the platform to not only treat chronic pain, but PTSD, alcohol and drug abuse, smoking and other issues in which mental health and physical discomfort collide.

“This is not the final product,” he says. “There’s a lot more that can be done.”

And as healthcare providers, public health agencies and federal and state governments pour time and money into telehealth and mHealth treatments to combat opioid addiction and substance abuse, it’s important to remember that these platforms are still evolving.

As the technology has only been in use for three months, Lee says it will take time to gather enough data to determine its effectiveness. But that’s what mHealth can do – give providers information about their patients’ daily activities, including their mental health. Over time, they’ll have enough data to identify trends, causes and effects.

“This is a great tool,” Lee says of the mHealth platform. “We now have the chance to treat the whole patient.”

 

https://mhealthintelligence.com/news/telehealth-can-connect-the-dots-between-chronic-pain-mental-health

By |September 27th, 2018|Categories: News||Comments Off

Dr. Pryzbylkowski of Relievus became one of the first Physicians in the state to offer a minimally invasive solution

As we get older, all individuals hope to keep their mobility, freedom and independence. Day to day tasks, such as walking to get the mail or standing to cook dinner can become laborious or even impossible, often due to a diagnosis of Lumbar Stenosis. On Wednesday September 19th, 2018, Dr. Pryzbylkowski of Relievus became one of the first Physicians in the state to offer a minimally invasive solution to patients suffering from this disease.

Lumbar spinal stenosis (LSS) is primarily a degenerative, age-related narrowing of the lower spinal canal that is diagnosed in more than 1.2 million individuals in the U.S. each year. Onset typically occurs after the age of 50 and these symptoms include pain and numbness in the lower back, legs or buttocks, which limits the patient’s ability to stand and walk.

Vertos developed the MILD procedure to help treat this growing population of patients who are saying no to more invasive, spine destabilizing and costly surgeries. MILD is a Minimally Invasive Lumbar Decompression, in which a Physician removes excess ligament through a 5.1mm portal – with no incisions, sutures or overnight stays.

Click here to see more detail information

By |September 27th, 2018|Categories: News||Comments Off

Courier Post

Screen Shot 2018-08-29 at 2.37.09 PM

By |August 29th, 2018|Categories: News||Comments Off

Voice of the People, July 2, 2018

https://www.pressofatlanticcity.com/opinion/letters/voice-of-the-people-july/article_9935a962-e266-5bbc-9265-8a48d5bad002.html

By |July 24th, 2018|Categories: News||Comments Off

Burlington County Times

http://www.burlingtoncountytimes.com/opinion/20180704/letters-to-editor-for-july-4

By |July 24th, 2018|Categories: News||Comments Off

Northeast Times

https://northeasttimes.com/letters-to-the-editor-2be645a1c7c9

By |July 23rd, 2018|Categories: News||Comments Off